CAESAREA, Israel, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital health company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders,

Initial findings show potential for material short-term annual savings of up to $5,000 per cardiovascular patient when treated for sleep apnea CAESAREA, Israel, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company leading

- Third Quarter Revenues Increase 36 % to $ 11.0 Million - - U.S. WatchPAT TM Revenues Increase 55 % t o $ 8.9 M illion – -Full Year 2020 Revenue Guidance of $39.5 Million to $40.5 Million - - Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT - CAESAREA, Israel, Nov.

CAESAREA, Israel, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders, announced today

CAESAREA, Israel, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the diagnosis of sleep apnea and other respiratory sleep disorders, today announced that Shane Brown has been appointed President – U.S.,

Q3 Total Revenue Results of $10.7 M to $ 11 . 0 M , reflecting growth of 32 %- 36 % Q3 U.S. WatchPAT Revenue Results of $8.6 M to $ 8. 9M , reflecting growth of 51 %- 56 % Full Year 2020 Revenue Guidance of $ 39. 5M to $40. 5 M CAESAREA, Israel, Oct. 13, 2020 (GLOBE NEWSWIRE) --  Itamar Medical

WASHINGTON, Oct. 5, 2020 /PRNewswire/ -- The National Sleep Foundation (NSF) named Itamar Medical Ltd. (NASDAQ and TASE: ITMR) winner of the 2020 SleepTech® Award. The SleepTech® Award recognizes the year's most innovative efforts in advancing sleep technology.

CAESAREA, Israel, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the diagnosis of sleep apnea and other respiratory sleep disorders, announced that its flagship WatchPAT™300 Home Sleep Apnea Testing

Updated guidelines represent a significant milestone in the adoption of Itamar’s Peripheral Arterial Tonometry (PAT) based Home Sleep Apnea Testing (HSAT) in Europe, following adoption in the UK, Holland, and Sweden CAESAREA, Israel, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd .

CAESAREA, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital health company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders,